Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Haihe Biopharma Co., Ltd.
Scientific Title
Open Label, Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of CYH33, an Oral PI3K Inhibitor in Combination With Olaparib, an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.